Table 4.
Reference | |
---|---|
IGF-I | |
Prediction of ITx patients requiring intensive nutritional intervention following transplant | [76] |
Index of IF in children with SBS | [75] |
Monitoring of recombinant GH treatment | [77] |
Monitoring of PN and nitrogen balance | [74] |
Indicator of short-term change in nutritional status | [36] |
Prediction of refeeding risk and mortality | [98] |
Diagnosis of acromegaly | [99] |
Diagnosis of growth hormone deficiency | [99] |
| |
IGF-II | |
Diagnosis of NICTH | [13] |
Monitoring of refeeding | [34] |
| |
IGFBP-1 | |
Assessment of insulin resistance and cardiovascular risk | [96] |
Marker for metabolic syndrome | [53] |
Prediction of growth failure in chronic renal disease | [97] |
Prediction of development of insulin resistance in children | [54] |
Monitoring of life-style interventions | [95] |
| |
IGFBP-2 | |
Marker for metabolic syndrome | [55] |
Diagnosis of NICTH | [100] |
| |
IGFBP-3 | |
Monitoring of nutritional status | [58] |
Assessment of GH status | [101] |
Monitoring of GH treatment | [101] |
Key: ITx: intestinal transplant; IF: intestinal failure; SBS: short bowel syndrome; NICTH: non-islet cell tumour hypoglycaemia.